Log in to save to my catalogue

Is IL-6 an appropriate target to treat spondyloarthritis patients refractory to anti-TNF therapy? a...

Is IL-6 an appropriate target to treat spondyloarthritis patients refractory to anti-TNF therapy? a...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3446419

Is IL-6 an appropriate target to treat spondyloarthritis patients refractory to anti-TNF therapy? a multicentre retrospective observational study

About this item

Full title

Is IL-6 an appropriate target to treat spondyloarthritis patients refractory to anti-TNF therapy? a multicentre retrospective observational study

Publisher

England: BioMed Central Ltd

Journal title

Arthritis research & therapy, 2012-03, Vol.14 (2), p.R53-R53, Article R53

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

The aim of this study was to evaluate, under real-life conditions, the safety and efficacy of tocilizumab in patients having failed anti-TNFα therapy for spondyloarthritis.
French rheumatologists and internal-medicine practitioners registered on the Club Rhumatismes et Inflammations website were asked to report on patients given tocilizumab (4 o...

Alternative Titles

Full title

Is IL-6 an appropriate target to treat spondyloarthritis patients refractory to anti-TNF therapy? a multicentre retrospective observational study

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3446419

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3446419

Other Identifiers

ISSN

1478-6354

E-ISSN

1478-6354,1478-6362

DOI

10.1186/ar3766

How to access this item